Table 4.
Univariate and multivariate analysis of variables affecting overall survival (post-PSM)
| Variable | Univariate | Multivariate | ||||
|---|---|---|---|---|---|---|
| P value | HR | 95% CI | P value | HR | 95% CI | |
| Sex | 0.840 | 1.162 | 0.269–5.015 | |||
| Maximum tumor diameter (<3/3–5/>5 cm) | 0.064 | 2.326 | 0.953–5.676 | |||
| Number of tumors (single/multiple) | 0.135 | 1.963 | 0.811–4.750 | |||
| MVI | 0.133 | 2.174 | 0.789–5.989 | |||
| Cirrhosis | 0.046a | 7.771 | 1.038–58.161 | 0.056 | 7.340 | 0.951–56.646 |
| IHC (HBsAg) (−/+) | 0.046a | 2.485 | 1.015–6.081 | 0.018a | 3.579 | 1.240–10.333 |
| C-reactive protein | 0.031a | 2.863 | 1.098–7.463 | 0.466 | 1.482 | 0.514–4.270 |
| HBV DNA level, 10 000 IU/ml | 0.320 | 1.671 | 0.607–4.600 | |||
| Ascites | 0.012a | 3.183 | 1.295–7.822 | 0.004a | 4.287 | 1.589–11.565 |
| AFP (ng/ml, ≤400/>400) | 0.021a | 2.817 | 1.166–6.807 | 0.001a | 4.777 | 1.907–11.966 |
AFP, alpha-fetoprotein; CI, confidence interval; HBV, hepatitis B virus; HR, hazard ratio; MVI, microvascular invasion.
Statistically significant.